Epidemiology, Clinical Characteristics and Outcomes of Extensively Drug-Resistant Acinetobacter baumannii Infections among Solid Organ Transplant Recipients

Host-microbe interactions that shape the pathogenesis ofAcinetobacter baumanniiinfection

(2012) Brittany L. Mortensen et al.   CELLULAR MICROBIOLOGY

Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies

(2012) Y. Cai et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace

(2012) Ignasi Roca et al.   Frontiers in Microbiology

Impact of Carbapenem Resistance and Receipt of Active Antimicrobial Therapy on Clinical Outcomes of Acinetobacter baumannii Bloodstream Infections

(2011) John S. Esterly et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

(2011) A.-P. Magiorakos et al.   CLINICAL MICROBIOLOGY AND INFECTION

High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimen

(2011) Ryan K. Shields et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Synergistic activity of sulbactam combined with colistin against colistin-resistant Acinetobacter baumannii

(2011) Marie Kempf et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

The Registry of the International Society for Heart and Lung Transplantation: Fourteenth Pediatric Lung and Heart-Lung Transplantation Report—2011

(2011) Christian Benden et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Five-year outcomes with alemtuzumab induction after lung transplantation

(2011) Susan Shyu et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients

(2011) Shahid Husain et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

High Mortality Associated With Acinetobacter Species Infection in Liver Transplant Patients

(2011) Y.J. Kim et al.   TRANSPLANTATION PROCEEDINGS

Synergy Testing by Etest, Microdilution Checkerboard, and Time-Kill Methods for Pan-Drug-Resistant Acinetobacter baumannii

(2010) M. M. Sopirala et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Multiresistant Gram-negative infections: a global perspective

(2010) Jennifer Ho et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Mortality Associated with Acinetobacter baumannii Infections Experienced by Lung Transplant Recipients

(2010) D. R. Nunley et al.   LUNG

PREDICTORS OF MORTALITY IN ADULT PATIENTS WITH VENTILATOR-ASSOCIATED PNEUMONIA

(2010) Ilias I. Siempos et al.   SHOCK

The detection of synergy between meropenem and polymyxin B against meropenem-resistant Acinetobacter baumannii using Etest® and time-kill assay

(2009) George A. Pankey et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Carbapenem-resistantAcinetobacter baumanniiinfections after organ transplantation

(2009) P. Reddy et al.   Transplant Infectious Disease

Pulmonary and Blood Stream Infections in Adult Living Donor and Cadaveric Liver Transplant Patients

(2009) Fuat H. Saner et al.   TRANSPLANTATION

In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii

(2009) Luigi Principe et al.   Annals of Clinical Microbiology and Antimicrobials

CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting

(2008) Teresa C. Horan et al.   AMERICAN JOURNAL OF INFECTION CONTROL

In Vitro Activities of Tigecycline, Minocycline, and Colistin-Tigecycline Combination against Multi- and Pandrug-Resistant Clinical Isolates of Acinetobacter baumannii Group

(2008) L. A. Arroyo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Genetic Basis of Multidrug Resistance in Acinetobacter baumannii Clinical Isolates at a Tertiary Medical Center in Pennsylvania

(2008) J. M. Adams-Haduch et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES

Acinetobacter baumannii: a universal threat to public health?

(2008) Helen Giamarellou et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: Characteristics and outcome in a series of 28 patients

(2008) Matthew E. Falagas et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii

(2008) Jennifer K. Mak et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Multidrug-resistant Acinetobacter baumannii Pneumonia in Lung Transplant Recipients

(2008) Madhuri M. Sopirala et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia

(2008) Alex P. Betrosian et al.   JOURNAL OF INFECTION

Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces

(2007) H.-W. Lee et al.   CLINICAL MICROBIOLOGY AND INFECTION